La spironolactone dans l'hirsutisme idiopathique, évaluations clinique et biologique du traitement = Spironolactone in idiopathic hirsutism. Clinical and biological evaluations of treatmentABRAMOVICI, Y; GUILLET, F; MATTE, R et al.Annales d'endocrinologie. 1983, Vol 44, Num 6, pp 393-396, issn 0003-4266Article

Stereoselective synthesis of the two major metabolites of spironolactone, 3α- and 3β-hydroxy-7α-methylthio-17α-pregn-4-ene-21,17-carbolactoneGUO LI; YAN ZHANG.Steroids. 2007, Vol 72, Num 6-7, pp 569-572, issn 0039-128X, 4 p.Article

Determination of an aldosterone antagonist in urine by high-performance liquid chromatography using automated column switchingTIMM, U; SANER, A.Journal of chromatography. 1986, Vol 378, Num 1, pp 25-34, issn 0021-9673Article

ALDOSTERONE ANTAGONISTS IN CLINICAL MEDICINE1978; EXCERPTA MED., INTERNATION. CONGR. SER.; NLD; DA. 1978; NO 460; PP. 1-527; BIBL. DISSEM.Conference Paper

Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenatesLUZZANI, F; GLASSER, A.Biochemical pharmacology. 1984, Vol 33, Num 14, pp 2277-2281, issn 0006-2952Article

Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolitesGARDINER, P; SCHRODE, K; QUINLAN, D et al.Journal of clinical pharmacology. 1989, Vol 29, Num 4, pp 342-347, issn 0091-2700Article

Pharmacokinetics of spironolactone and potassium canrenoate in humansKOJIMA, K; YAMAMOTO, K; FUJIOKA, H et al.Journal of pharmacobio-dynamics. 1985, Vol 8, Num 3, pp 161-166, issn 0386-846XArticle

Spironolactone in the treatment of premenstrual tension : a double-blind study of spironolactone versus bendroflumethiazide and placeboASLAKSEN, K; FALK, V.Current therapeutic research. 1991, Vol 49, Num 1, pp 120-130, issn 0011-393X, 11 p.Article

Protective effect of spironolactone on endothelial cell apoptosisWILLIAMS, Tracy A; VERHOVEZ, Andrea; MILAN, Alberto et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 5, pp 2496-2505, issn 0013-7227, 10 p.Article

Pharmacokinetics and metabolism of [¹⁴C]eplerenone after oral administration to humansCOOK, Chyung S; BERRY, Loren M; BIBLE, Roy H et al.Drug metabolism and disposition. 2003, Vol 31, Num 11, pp 1448-1455, issn 0090-9556, 8 p.Article

Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural/electrical remodelingMAYYAS, Fadia; ALZOUBI, Karem H; VAN WAGONER, David R et al.International journal of cardiology. 2013, Vol 168, Num 6, pp 5135-5142, issn 0167-5273, 8 p.Article

Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once AppearedMARTINEZ, Felipe A.Cardiovascular drugs and therapy. 2010, Vol 24, Num 4, pp 345-350, issn 0920-3206, 6 p.Conference Paper

Endothelial function and the effects of aldosterone blockadeSUDANO, Isabella; RUSCHITZKA, Frank; NOLL, Georg et al.European heart journal supplements. 2011, Vol 13, Num B, issn 1520-765X, B21-B26Article

Current guidelines for treatment of heart failure : 2006 updateUDDIN, Nabil; PATTERSON, J. Herbert.Pharmacotherapy. 2007, Vol 27, Num 4, issn 0277-0008, 12S-17S, 2Article

INTOXICATION A LA GLYCYRRHIZINE CHEZ UN CIRRHOTIQUE. INEFFICACITE DU TRAITEMENT ANTIALDOSTERONIQUE AU COURS D'UNE DECOMPENSATION OEDEMATO-ASCITIQUEAUDHUY B; PINGET M; DORNER M et al.1980; J. MED. STRASBOURG; FRA; DA. 1980; VOL. 11; NO 6; PP. 330-331; BIBL. 5 REF.Article

EFFECT OF SPIROLACTONE TREATMENT ON THE RENIN-ALDOSTERONE SYSTEM DURING PREGNANCYLAMMINTAUSTA R; ERKKOLA R.1979; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1979; VOL. 17; NO 7; PP. 294-298; BIBL. 30 REF.Article

ACTION DES SPIROLACTONES SUR LE METABOLISME SURRENALIENAUBRY MARAIS FLORENCE.1979; ; FRA; DA. 1979; 114 P.; 30 CM; BIBL. 7 P.; TH. UNIV.: SCI/PARIS 6/1979Thesis

FATAL HYPERKALEMIA AND HYPERCHLOREMIC ACIDOSIS: ASSOCIATION WITH SPIRONOLACTONE IN THE ABSENCE OF RENAL IMPAIRMENTFEINFELD DA; CARVOUNIS CP.1978; J.A.M.A.; USA; DA. 1978; VOL. 240; NO 14; PP. 1516; BIBL. 10 REF.Article

LES INHIBITEURS DE L'ALDOSTERONEVIGY M.1978; CONCOURS MED.; FRA; DA. 1978; VOL. 100; NO 45; PP. 7535-7540Article

PLASMA CORTICOSTEROID CONCENTRATIONS DURING SPIRONOLACTONE ADMINISTRATION: EVIDENCE FOR ADRENAL BIOSYNTHETIC BLOCKADE IN MANTUCK ML; SOWERS JR; FITTINGOFF DB et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 6; PP. 1057-1061; BIBL. 28 REF.Article

LE MECANISME D'ACTION D'UN HYPOTENSEUR ETUDIE PAR L'ANALYSE DU CAROTIDOGRAMME: APPLICATION AUX ANTIALDOSTERONESMEYER HEINE A; ANSQUER JC; HAYOUN C et al.1981; THERAPIE; ISSN 0040-5957; FRA; DA. 1981; VOL. 36; NO 6; PP. 623-630; ABS. ENG; BIBL. 12 REF.Article

A STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF SPIROLACTONES: CONTRIBUTION OF THE CYCLOPROPANE RING TO ANTIMINERALOCORTICOID ACTIVITYCHINN LJ; SALAMON KW; DESAI BN et al.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 9; PP. 1103-1107; BIBL. 14 REF.Article

UTILISATION DE CANRENOATE DE POTASSIUM, ANTAGONISTE DE L'ALDOSTERONE CHEZ LES MALADES ATTEINTS D'INSUFFISANCE CARDIO-VASCULAIRE CHRONIQUESIDORENKO BA; KUDISOV YU M; ROSSEL'S AN et al.1979; KARDIOLOGIJA; SUN; DA. 1979; VOL. 19; NO 3; PP. 41-46; ABS. ENG; BIBL. 8 REF.Article

ALDOSTERONE ET ANTIALDOSTERONES.1978; REV. MED.; FR.; DA. 1978; VOL. 19; NO 1-2; PP. 5-42; ABS. ANGL.; BIBL. DISSEM.Article

DOSE-RESPONSE RELATIONSHIP FOR SPIRONOLACTONE AT STEADY STATEMCINNES GT; PERKINS RM; SHELTON JR et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 3; PP. 317-323; BIBL. 34 REF.Article